C-erbB-2 overexpression in primary breast cancer: independent prognostic factor in patients at high risk (Q72686777)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7914107%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

C-erbB-2 overexpression in primary breast cancer: independent prognostic factor in patients at high risk (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7914107%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

author name string

I Schönborn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7914107%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

W Zschiesche

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7914107%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

E Spitzer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7914107%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

C Minguillon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7914107%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

M Möhner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7914107%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

K Ebeling

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7914107%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

R Grosse

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7914107%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7914107%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

28 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7914107%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7914107%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7914107%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

287-295

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7914107%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00666483

28 October 2019

exact match

0 references

cites work

Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer

1 reference

12 December 2020

Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer

1 reference

12 December 2020

Breast cancer and combined oral contraceptives: results from a multinational study. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives

1 reference

12 December 2020

HER-2/neu oncogene protein and prognosis in breast cancer

1 reference

12 December 2020

The Nottingham prognostic index in primary breast cancer

1 reference

12 December 2020

Correlation of HER-2/neu amplification with expression and with other prognostic factors in 1103 breast cancers

1 reference

12 December 2020

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

12 December 2020

Association of elevated expression of the c-erbB-2 protein with spread of breast cancer.

1 reference

12 December 2020

Human breast cancer: identification of populations with a high risk of early relapse in relation to both oestrogen receptor status and c-erbB-2 overexpression

1 reference

12 December 2020

Prognostic significance of her-2/neu expression in breast cancer and its relationship to other prognostic factors

1 reference

12 December 2020

c-myc, c-erbB-2, and Ki-67 expression in normal breast tissue and in invasive and noninvasive breast carcinoma

1 reference

12 December 2020

Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.

1 reference

12 December 2020

The value of morphometry to classic prognosticators in breast cancer.

1 reference

12 December 2020

Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features

1 reference

12 December 2020

HER-2 oncogene amplification and overall survival of breast carcinoma patients

1 reference

12 December 2020

A prognostic index in primary breast cancer

1 reference

12 December 2020

Combined oral contraceptives containing chlormadinone acetate and breast cancer: results of a case-control study

1 reference

12 December 2020

The long term prognostic significance of c-erbB-2 in primary breast cancer

1 reference

12 December 2020

c-erbB-2 oncogene as a prognostic marker in breast cancer

1 reference

12 December 2020

C-erbB2 mRNA expression in human breast tumours: comparison with c-erbB2 DNA amplification and correlation with prognosis

1 reference

12 December 2020

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)

1 reference

12 December 2020

Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up

1 reference

12 December 2020

c-erbB-2 positive breast tumours behave more aggressively in the first years after diagnosis

1 reference

12 December 2020

Immunohistochemical demonstration of c-erb B-2 oncoprotein expression in female breast cancer and its prognostic significance

1 reference

12 December 2020

Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer

1 reference

12 December 2020

c-erbB-2 oncoprotein expression in primary and advanced breast cancer

1 reference

12 December 2020

Prognostic factors in breast-cancer (review).

1 reference

12 December 2020

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

1 reference

12 December 2020

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma

1 reference

12 December 2020

Histologic types of breast carcinoma in relation to international variation and breast cancer risk factors. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.

1 reference

12 December 2020

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes

1 reference

12 December 2020

Proliferating cell nuclear antigen in breast lesions: correlation of c-erbB-2 oncoprotein and EGF receptor and its clinicopathological significance in breast cancer

1 reference

12 December 2020

Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-up

1 reference

12 December 2020

The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancer

1 reference

12 December 2020

c-erbB2 expression in correlation to other biological parameters of breast cancer

1 reference

12 December 2020

Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer

1 reference

12 December 2020

A computer program for comparing K samples with right-censored data

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00666483

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7914107%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference